FCC ID 2AA923614-04

In Touch Blood Glucose Monitoring System

by Livongo Health, Inc.

Grantee Code: 2AA92   Product Code: 361404
Latest application date: 2013-12-15

FCC ID Device Details

FCC ID2AA923614-04
Mirrorsfcc.id | gov | fccid.ai
Grantee Code2AA92
Product Code361404
Applicant BusinessLivongo Health, Inc. 🇺🇸
Related Domains eoshealth.com
Equipment ClassIn Touch Blood Glucose Monitoring System
Test FirmUL VS Ltd

Operating Frequencies

Frequency RangeApplication PurposeFinal Action Date
824.2-848.8 MHzOriginal Equipment2013-12-15

Exhibits

DocumentTypeAvailableFile
Owners manualUsers Manual2014-06-13PDF 1.3 MB
Internal photosInternal Photos2014-06-13PDF 342.7 KB
External photosExternal Photos2014-06-13PDF 1.3 MB
LabelID Label/Location Info2013-12-15PDF 317.9 KB
Label locationID Label/Location Info2013-12-15PDF 653.5 KB
Test setupTest Setup Photos2014-06-13PDF 334.3 KB
Test reportTest Report2013-12-15PDF 998.2 KB
CoC letterAttestation Statements2013-12-15PDF 23.1 KB
Permission letterAttestation Statements2013-12-15PDF 823.3 KB
Reference letterAttestation Statements2013-12-15PDF 92.5 KB
Authorisation letterCover Letter(s)2013-12-15PDF 36.4 KB
Confidentiality letterCover Letter(s)2013-12-15PDF 35.1 KB
SAR justificationRF Exposure Info2013-12-15PDF 115.4 KB

Application Information

Application ID/hOApqJWm6yfWDRS9YoVdQ==
Final Action Date2013-12-15
Application PurposeOriginal Equipment
Applicant FRN0023086168
Model3614-04
Frequency Range824.2-848.8 MHz
Equipment ClassPCB - PCS Licensed Transmitter
Device DescriptionIn Touch Blood Glucose Monitoring System
Responsible PartyKimon Jerry Angelides, Chief Executive Officer, kangelides@eoshealth.com , 8664355643
Test FirmJohn Newell, UL VS Ltd, john.newell@ul.com , 00-44-1256-312000
TCB EmailTom.Twynam@babt.com
TCB ScopeB1: Commercial mobile radio services equipment in the following 47 CFR Parts 20, 22 (cellular), 24,25 & 27
Short-Term ConfidentialityYes
Short-Term Confidentiality Date06/13/2014
Long-Term ConfidentialityYes
Grant DeferralNo
Modular EquipmentDoes not apply
Composite DeviceNo
Composite PartNo
Cognitive RadioNo
Authorization WaiverNo
Authorization Waiver ApprovedNo
Section 5301 CertificationYes
Related OET Knowledge DataBase InquiryNo
Grant CommentsPower listed is conducted. Device must operate with a maximum duty factor not exceeding that described in this filing. The duty factor must be implemented in factory firmware. The antenna(s) used for this transmitter must not be co-located or operating in conjunction with any other antenna or transmitter except in accordance with FCC multi-transmitter evaluation procedures. This device contains functions that are not operational in U.S. Territories. This filing is only applicable for U.S. operations.

Applications

Application IDDatePurpose
/hOApqJWm6yfWDRS9YoVdQ==2013-12-15Original Equipment

Equipment Authorization

FrequencyOutputToleranceEmissionRules
824.2-848.8 MHz1.7415Hz300KGXW22H
1850.2-1909.8 MHz115Hz300KGXW24E

Grants

TCB Grant - Application /hOApqJWm6yfWDRS9YoVdQ==

TCB GRANT OF EQUIPMENT
AUTHORIZATION
TCB
Certification
Issued Under the Authority of the
Federal Communications Commission
By:

  TUV SUD BABT
Octagon House, Concorde Way, Segensworth North,
Fareham, PO15 5RL
United Kingdom
Date of Grant: 12/15/2013

Application Dated: 12/15/2013
EosHealth, Inc.
2800 Post Oak Boulevard
41st Floor
Houston, TX 77057
 
Attention: Kimon Angelides , Chief Executive Officer

NOT TRANSFERABLE
EQUIPMENT AUTHORIZATION is hereby issued to the named GRANTEE, and is VALID ONLY for the equipment identified hereon for use under the Commission's Rules and Regulations listed below.
 
FCC IDENTIFIER:  2AA923614-04
Name of Grantee:  EosHealth, Inc.
Equipment Class: PCS Licensed Transmitter
Notes: In Touch Blood Glucose Monitoring System
Grant Notes  FCC Rule Parts Frequency
Range (MHZ)
Output
Watts
Frequency
Tolerance
Emission
Designator
22H 824.2  -  848.8 1.74 15.0  Hz 300KGXW
24E 1850.2  -  1909.8 1.0 15.0  Hz 300KGXW

Power listed is conducted. Device must operate with a maximum duty factor not exceeding that described in this filing. The duty factor must be implemented in factory firmware. The antenna(s) used for this transmitter must not be co-located or operating in conjunction with any other antenna or transmitter except in accordance with FCC multi-transmitter evaluation procedures.

This device contains functions that are not operational in U.S. Territories. This filing is only applicable for U.S. operations.


EAS Grant - Application /hOApqJWm6yfWDRS9YoVdQ==

COPY FEDERAL COMMUNICATIONS
COMMISSION
WASHINGTON, D.C. 20554

GRANT OF EQUIPMENT
AUTHORIZATION
COPY
Certification

EosHealth, Inc.
2800 Post Oak Boulevard 41st Floor
Houston, TX 77057
United States
  Date of Grant: 12/15/2013

Application Dated: 12/15/2013
 
Attention: Kimon Angelides , Chief Executive Officer

NOT TRANSFERABLE
EQUIPMENT AUTHORIZATION is hereby issued to the named GRANTEE, and is VALID ONLY for the equipment identified hereon for use under the Commission's Rules and Regulations listed below.
 
FCC IDENTIFIER:  2AA923614-04
Name of Grantee:  EosHealth, Inc.
Equipment Class: PCS Licensed Transmitter
Notes: In Touch Blood Glucose Monitoring System
Modular Type: Does not apply
Grant Notes  FCC Rule Parts Frequency
Range (MHZ)
Output
Watts
Frequency
Tolerance
Emission
Designator
22H 824.2  -  848.8 1.74 15.0  Hz 300KGXW
24E 1850.2  -  1909.8 1.0 15.0  Hz 300KGXW

Power listed is conducted. Device must operate with a maximum duty factor not exceeding that described in this filing. The duty factor must be implemented in factory firmware. The antenna(s) used for this transmitter must not be co-located or operating in conjunction with any other antenna or transmitter except in accordance with FCC multi-transmitter evaluation procedures.

This device contains functions that are not operational in U.S. Territories. This filing is only applicable for U.S. operations.



Mail To: